Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab

Chiara Pirrone, Caterina De Grandis, Francesco Pepe et al.|European Journal of Cancer|2025

Cited by 3